SIR -In his Correspondence 'Caution urged in trial of stem cells to treat spinal-cord injury' (Nature 458, 29; 2009), Yves Barde questions the wisdom of testing oligodendrocyte precursors derived from embryonic stem (ES) cells in patients, despite the promise that such cells hold for repairing these injuries in rodents.
After traumatic injury to the spinal cord, the axons adjacent to the lesion often remain intact but become demyelinated (J. Silver and J. H. Miller Nature Rev. Neurosci. 5, 146-156; 2004 Despite generous support for all branches of science in the two years leading up to Romania's accession to the European Union in 2007, the latest financial situation is impeding progress just as it was starting to gather momentum. The research budget for this year has been cut back to about 40% of what it was in 2008. Successful projects that won funding last year are slowing to a halt, along with the ascent of academia and industry.
But it is not just a matter of curbed expenditure. Science lobbyists and policy-makers should have used the financial crisis as an opportunity to apply more stringent funding criteria to raise the quality of scientific output and accelerate progress. Romania cannot actively compete in today's scientific and economic arenas without stimulating scientific creativity. 
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